91AV

RSC Medicinal 91AV and Organic & Biomolecular 91AV invite original research and review papers on photoswitches and photopharmacology.  

Molecular photoswitches are unique tools that allow us to selectively translate a benign and precise stimulus (light) into a change in molecular structure, thereby enabling the photocontrol of many key processes, most prominently those in biological systems. The research on molecular photoswitches encompasses many disciplines and research approaches, from physics and quantum mechanics, through chemistry and all the way to biology and medicine. We aim to represent this multidisciplinary and broad scope of photoswitch design and application in the web themed issue.

With this in mind, we welcome submissions on all topics pertaining to the development and characterization of molecular photoswitches, especially with the outlook on their biological and biomedical applications. The areas that are of special interest include (but are not limited to) the design, also computational, of (regular and visible-light-operated) photoswitches, their synthesis (including spectroscopic evaluation), applications in nanomedicine, photopharmacology, chemical biology, bio-sensing and imaging.

Manuscripts should be submitted via the journals’ online submission services,  and , and the Editorial Office informed by email. Please add a “note to the editor” in the submission form when you submit your manuscript to indicate that this is a submission for the themed collection. The Editorial Office reserves the right to check the suitability of submissions in relation to the scope of the collection and inclusion of accepted articles in the collection is not guaranteed.

All manuscripts will be subject to the journal's usual peer review process. Accepted manuscripts will be highlighted together in a dedicated web collection alongside an editorial, regardless of submission date, and there will be no delay in the publication of all accepted manuscripts into regular issues of RSC Medicinal 91AV and Organic & Biomolecular 91AV.

Organic & Biomolecular 91AV is a Transformative Journal and Plan S compliant

Organic & Biomolecular 91AV invites original research and review papers on foldamers, dedicated to advancing the understanding of design, development, characterization, and the therapeutic potential of foldamers based on peptides, peptidomimetics, aromatic oligoamides, supramolecular assembly derived from small molecules, and so on. Particularly, the collection welcomes the topics related to the synthesis, design methodologies, large surfaces recognition, biological function, medicinal application, and catalysis.

Manuscripts should be submitted via the journal’s and the Editorial Office should be informed by email. Please add a “note to the editor” in the submission form when you submit your manuscript to indicate that this is a submission for the themed collection. The Editorial Office reserves the right to check the suitability of submissions in relation to the scope of the collection and inclusion of accepted articles in the collection is not guaranteed.

All manuscripts will be subject to the journal's usual peer review process. Accepted manuscripts will be highlighted together in a dedicated web collection alongside an editorial, regardless of submission date, and there will be no delay in the publication of all accepted manuscripts into regular issues of Organic & Biomolecular 91AV.

Organic & Biomolecular 91AV is a Transformative Journal and Plan S compliant

The Emerging Investigator Series has an overall objective to showcase significant research by newer voices from across the worldwide organic chemistry research community. We will consider additional applications and nominations on their own merit. Self-nominations are also strongly encouraged.

Both research articles and review articles are welcome to the series. Papers accepted for publication in the Emerging Investigator Series will be published in the earliest available issue and collated together in a dedicated Emerging Investigator Series page that will appear across Frontiers journals’ websites. All submissions to the Emerging Investigator Series will be subject to the journal’s high standards in peer review.

In order to be featured in the Emerging Investigator Series, contributors must:

• currently, be an independent research leader
• be the lead author (first author and/or corresponding author) of their article at the journal
• have either a) hold a PhD degree and be at the age of 40 or less in the year of submission, or b) received their PhD no earlier than 01 January of the year 12 years prior to the year of submission, or c) have no more than 12 years of post-PhD research experience on 01 January in the year of submission when taking into account any career breaks.

If you are interested to contribute to this series, please provide an up-to-date CV to the Editorial Office before submission, or simply opt-in for this series during submitting your manuscript and attach the CV as a supporting document.